Hsbc Holdings PLC Bio Techne Corp Transaction History

Hsbc Holdings PLC

$159 Billion
Q1 2025

A detailed history of Hsbc Holdings PLC transactions in Bio Techne Corp stock. As of the latest transaction made, Hsbc Holdings PLC holds 526,124 shares of TECH stock, worth $28 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

526,124

Previous 268,472 95.97%

Holding current value

$28 Million

Previous $19.3 Million 59.51%

% of portfolio

0.02%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$58.47 - $78.75 $15.1 Million - $20.3 Million	257,652 Added 95.97%	526,124 $30.8 Million
Q4 2024 Feb 14, 2025	BUY	$66.37 - $78.17 $1.43 Million - $1.68 Million	21,483 Added 8.7%	268,472 $19.3 Million
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $3.18 Million - $3.69 Million	-44,817 Reduced 15.36%	246,989 $19.7 Million
Q2 2024 Aug 12, 2024	SELL	$62.12 - $84.15 $1.57 Million - $2.13 Million	-25,264 Reduced 7.97%	291,806 $20.9 Million
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $3.68 Million - $4.29 Million	55,700 Added 21.31%	317,070 $22.3 Million
Q4 2023 Feb 12, 2024	BUY	$52.83 - $78.22 $4.92 Million - $7.28 Million	93,107 Added 55.33%	261,370 $20.2 Million
Q3 2023 Nov 13, 2023	SELL	$67.52 - $89.42 $4.56 Million - $6.04 Million	-67,546 Reduced 28.64%	168,263 $11.5 Million
Q2 2023 Aug 11, 2023	SELL	$73.76 - $85.98 $1.53 Million - $1.79 Million	-20,808 Reduced 8.11%	235,809 $19.2 Million
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $2.44 Million - $2.95 Million	-34,029 Reduced 11.71%	256,617 $19 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $21.2 Million - $92.8 Million	263,301 Added 962.89%	290,646 $24.1 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $732,061 - $1.02 Million	-2,591 Reduced 8.66%	27,345 $7.81 Million
Q2 2022 Aug 11, 2022	BUY	$322.67 - $449.65 $31,944 - $44,515	99 Added 0.33%	29,936 $10.4 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $6.17 Million - $8.51 Million	-17,445 Reduced 36.9%	29,837 $13.1 Million
Q4 2021 Feb 11, 2022	BUY	$456.15 - $525.06 $8.66 Million - $9.97 Million	18,982 Added 67.07%	47,282 $24.5 Million
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $9.09 Million - $11 Million	20,441 Added 260.1%	28,300 $13.8 Million
Q2 2021 Aug 13, 2021	BUY	$387.35 - $450.26 $1.39 Million - $1.62 Million	3,591 Added 84.14%	7,859 $3.54 Million
Q1 2021 May 14, 2021	SELL	$314.62 - $411.0 $2.99 Million - $3.9 Million	-9,491 Reduced 68.98%	4,268 $1.63 Million
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $2.95 Million - $3.85 Million	11,952 Added 661.43%	13,759 $4.37 Million
Q3 2020 Nov 12, 2020	SELL	$232.22 - $282.96 $173,236 - $211,088	-746 Reduced 29.22%	1,807 $449,000
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $540,157 - $814,358	-2,913 Reduced 53.29%	2,553 $674,000
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $406,309 - $558,426	2,521 Added 85.6%	5,466 $1.05 Million
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $321,317 - $376,220	1,694 Added 135.41%	2,945 $647,000
Q3 2019 Nov 14, 2019	BUY	$183.56 - $216.72 $229,633 - $271,116	1,251 New	1,251 $245,000
Q2 2019 Aug 13, 2019	SELL	$188.72 - $215.43 $512,186 - $584,677	-2,714 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$136.09 - $200.44 $10.2 Million - $15 Million	-74,702 Reduced 96.49%	2,714 $539,000
Q4 2018 Feb 13, 2019	BUY	$132.75 - $203.8 $9.96 Million - $15.3 Million	75,056 Added 3180.34%	77,416 $11.2 Million
Q3 2018 Nov 13, 2018	BUY	$147.44 - $204.11 $347,958 - $481,699	2,360 New	2,360 $481,000
Q2 2018 Aug 10, 2018	SELL	$144.9 - $165.58 $200,396 - $228,997	-1,383 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$131.46 - $151.04 $181,809 - $208,888	1,383 New	1,383 $209,000

Others Institutions Holding TECH

# of Institutions

628

Shares Held

160M

Call Options Held

90K

Put Options Held

14.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.08B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Bio Techne Corp Transaction History